Brief: Enorama Pharma AB Rights Issue Subscribed To 152 Percent
22/11/2018 07:07
Enorama Pharma AB ERMA.ST :
* RIGHTS ISSUE SUBSCRIBED TO 152 PERCENT
* GETS PROCEEDS OF ABOUT SEK 25.0 MILLION BEFORE ISSUE COSTS
THROUGH RIGHTS ISSUE
Source text for Eikon: ID:nWkr9qp011
Further company coverage: ERMA.ST
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO